Dunlop J - Search Results

1

Human A53T α-synuclein causes reversible deficits in mitochondrial function and dynamics in primary mouse cortical neurons.

Li L, Nadanaciva S, Berger Z, Shen W, Paumier K, Schwartz J, Mou K, Loos P, Milici AJ, Dunlop J, Hirst WD. Li L, et al. Among authors: dunlop j. PLoS One. 2013 Dec 31;8(12):e85815. doi: 10.1371/journal.pone.0085815. eCollection 2013. PLoS One. 2013. PMID: 24392030 Free PMC article.

2

Behavioral characterization of A53T mice reveals early and late stage deficits related to Parkinson's disease.

Paumier KL, Sukoff Rizzo SJ, Berger Z, Chen Y, Gonzales C, Kaftan E, Li L, Lotarski S, Monaghan M, Shen W, Stolyar P, Vasilyev D, Zaleska M, D Hirst W, Dunlop J. Paumier KL, et al. Among authors: dunlop j. PLoS One. 2013 Aug 1;8(8):e70274. doi: 10.1371/journal.pone.0070274. Print 2013. PLoS One. 2013. PMID: 23936403 Free PMC article.

3

Inhibition of glucosylceramide synthase stimulates autophagy flux in neurons.

Shen W, Henry AG, Paumier KL, Li L, Mou K, Dunlop J, Berger Z, Hirst WD. Shen W, et al. Among authors: dunlop j. J Neurochem. 2014 Jun;129(5):884-94. doi: 10.1111/jnc.12672. Epub 2014 Mar 3. J Neurochem. 2014. PMID: 24494600 Free article.

4

Phosphoproteomic evaluation of pharmacological inhibition of leucine-rich repeat kinase 2 reveals significant off-target effects of LRRK-2-IN-1.

Luerman GC, Nguyen C, Samaroo H, Loos P, Xi H, Hurtado-Lorenzo A, Needle E, Stephen Noell G, Galatsis P, Dunlop J, Geoghegan KF, Hirst WD. Luerman GC, et al. Among authors: dunlop j. J Neurochem. 2014 Feb;128(4):561-76. doi: 10.1111/jnc.12483. Epub 2013 Nov 11. J Neurochem. 2014. PMID: 24117733 Free article.

5

Screening of immunophilin ligands by quantitative analysis of neurofilament expression and neurite outgrowth in cultured neurons and cells.

Liu D, McIlvain HB, Fennell M, Dunlop J, Wood A, Zaleska MM, Graziani EI, Pong K. Liu D, et al. Among authors: dunlop j. J Neurosci Methods. 2007 Jul 30;163(2):310-20. doi: 10.1016/j.jneumeth.2007.03.018. Epub 2007 Apr 5. J Neurosci Methods. 2007. PMID: 17490751

6

Design and synthesis of a hybrid series of potent and selective agonists of α7 nicotinic acetylcholine receptor.

Nencini A, Castaldo C, Comery TA, Dunlop J, Genesio E, Ghiron C, Haydar S, Maccari L, Micco I, Turlizzi E, Zanaletti R, Zhang J. Nencini A, et al. Among authors: dunlop j. Eur J Med Chem. 2014 May 6;78:401-18. doi: 10.1016/j.ejmech.2014.03.031. Epub 2014 Mar 19. Eur J Med Chem. 2014. PMID: 24704613

7

Amiloride is neuroprotective in an MPTP model of Parkinson's disease.

Arias RL, Sung ML, Vasylyev D, Zhang MY, Albinson K, Kubek K, Kagan N, Beyer C, Lin Q, Dwyer JM, Zaleska MM, Bowlby MR, Dunlop J, Monaghan M. Arias RL, et al. Among authors: dunlop j. Neurobiol Dis. 2008 Sep;31(3):334-41. doi: 10.1016/j.nbd.2008.05.008. Epub 2008 Jul 7. Neurobiol Dis. 2008. PMID: 18606547

8

Purinergic receptor-mediated morphological changes in microglia are transient and independent from inflammatory cytokine release.

McIlvain HB, Ma L, Ludwig B, Manners MT, Martone RL, Dunlop J, Kaftan EJ, Kennedy JD, Whiteside GT. McIlvain HB, et al. Among authors: dunlop j. Eur J Pharmacol. 2010 Sep 25;643(2-3):202-10. doi: 10.1016/j.ejphar.2010.06.046. Epub 2010 Jul 13. Eur J Pharmacol. 2010. PMID: 20621081

9

The metabotropic glutamate receptor 7 allosteric modulator AMN082: a monoaminergic agent in disguise?

Sukoff Rizzo SJ, Leonard SK, Gilbert A, Dollings P, Smith DL, Zhang MY, Di L, Platt BJ, Neal S, Dwyer JM, Bender CN, Zhang J, Lock T, Kowal D, Kramer A, Randall A, Huselton C, Vishwanathan K, Tse SY, Butera J, Ring RH, Rosenzweig-Lipson S, Hughes ZA, Dunlop J. Sukoff Rizzo SJ, et al. Among authors: dunlop j. J Pharmacol Exp Ther. 2011 Jul;338(1):345-52. doi: 10.1124/jpet.110.177378. Epub 2011 Apr 20. J Pharmacol Exp Ther. 2011. PMID: 21508084

10

Ion channel screening plates: design, construction, and maintenance.

Mayer SC, Butera JA, Diller DJ, Dunlop J, Ellingboe J, Fan KY, Kaftan E, Mekonnen B, Mobilio D, Paslay J, Tawa G, Vasilyev D, Bowlby MR. Mayer SC, et al. Among authors: dunlop j. Assay Drug Dev Technol. 2010 Aug;8(4):504-11. doi: 10.1089/adt.2009.0239. Assay Drug Dev Technol. 2010. PMID: 20470241

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

640 results

Search Page